Oramed Pharmaceuticals ORMP
$ 2.35
0.43%
Quarterly report 2024-Q2
added 08-14-2024
Country |
Israel |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Nadav Kidron |
Employees in the company |
13 |
Shares |
40.3 M |
Market Cap[1] |
$ 94.7 M |
EBITDA (LTM) |
$ -27.6 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.